Technology News and Research

RSS

Dresden scientists get access to the World's second-fastest computer for cancer research

For their calculations, researchers at the Helmholtz-Zentrum Dresden-Rossendorf will now, starting in 2015, have access to the World's second-fastest computer. The Dresden research initiative is one of 56 projects the US Department of Energy has granted access to Titan as part of their INCITE program.

27 Nov 2014

New smartphone app may help improve prescribing of antibiotics within RCSI Hospitals Group

A new smartphone app has been developed by the RCSI (Royal College of Surgeons in Ireland) Hospitals Group, in association with the Dublin North East Healthcare-Associated Infection (HCAI) Committee, which will provide healthcare professionals in hospitals within the RCSI Hospitals Group with immediate access to guidelines for antimicrobial prescribing.

27 Nov 2014

Calcivis announces completion of first clinical study of Caries Activity Imaging System

Calcivis, a medical devices company focused on revolutionising the management of tooth decay, today announces that it has completed a first clinical study of its Calcivis® Caries Activity Imaging System.

27 Nov 2014

FDA issues Complete Response letter for Avanir’s AVP-825 NDA

Avanir Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has issued a Complete Response letter to its New Drug Application (NDA) for AVP-825.

27 Nov 2014

External artificial pancreas improves glucose control, reduces hypoglycemia risk

The world's first clinical trial comparing three alternative treatments for type 1 diabetes was conducted in Montréal by researchers at the IRCM and the University of Montreal, led by endocrinologist Dr. Rémi Rabasa-Lhoret.

27 Nov 2014

Researchers show that iPS cells can be used to edit genetic mutations that cause DMD

Researchers at the Center for iPS Cell Research and Application, Kyoto University, show that induced pluripotent stem (iPS) cells can be used to correct genetic mutations that cause Duchenne muscular dystrophy (DMD).

27 Nov 2014

Peek's smartphone eye examination tool could help tackle blindness

The team behind Peek, the Portable Eye Examination Kit, are calling on the public to help provide a solution to avoidable blindness by increasing access to potentially life-changing new eye health testing equipment.

27 Nov 2014

Innovative collar for MND patients to be showcased at NHS Innovation Challenge Prizes

MEDICAL technology designers are to pitch a new contoured support snood helping to improve the quality of lives of motor neurone disease sufferers whose neck muscles have weakened to a panel of Dragons’ Den style judges as part of a £10,000 innovation challenge.

27 Nov 2014

Researchers discover why advanced melanoma patients respond to pembrolizumab drug

Work supported by the Stand Up To Cance - Cancer Research Institute - Immunology Translational Research Dream Team, launched in 2012 to focus on how the patient's own immune system can be harnessed to treat some cancers have pioneered an approach to predict why advanced melanoma patients respond to a new life-saving melanoma drug.

27 Nov 2014

UT Arlington researcher receives grant to educate Hispanic patients about depression, treatment options

A University of Texas at Arlington researcher hopes to dispel myths about depression and its treatment, as well as reduce the stigma associated with receiving mental health care among Hispanics.

27 Nov 2014

Genom Austria project to explore impact of genome sequencing on science and society

In many countries, genome sequencing technology is now starting to become available in the clinic, where it helps to diagnose rare Mendelian diseases and contributes to personalized cancer therapy. The analysis of personal genomes also creates unprecedented opportunities for predictive health counseling, ancestry research, and many more applications that are just starting to emerge.

26 Nov 2014

CARsgen announces completion of series A financing

CARsgen, a leader in the development of Chimeric Antigen Receptors T (CAR-T) cell immunotherapy to treat a variety of cancers, today announced the completion of a series A financing led by BVCF, a China-based healthcare private equity fund.

26 Nov 2014

Philips announces expanded availability of diagnostic X-ray solutions

Royal Philips today announced expanded availability of its portfolio of diagnostic X-ray solutions, including DuraDiagnost, DigitalDiagnost, MobileDiagnost wDR, MobileDiagnost Opta, ProGrade and PrimaryDiagnost.

From Philips Healthcare 26 Nov 2014

Perc NGage® and Perc NCompass® nitinol stone extractors launched by Cook Medical

Urologists now have new options for stone extraction devices when performing percutaneous nephrolithotomy (PCNL), as Cook Medical is launching the Perc NGage® and Perc NCompass® nitinol stone extractors today. The new products complement the Perc NCircle®, which has been on the market since 2002 and was the first nitinol extraction device for percutaneous procedures. Cook Medical was the first company to incorporate nitinol into its stone extraction devices.

From COOK MEDICAL INC. 26 Nov 2014

Orgenesis receives €2.015 million grant to develop potential cure for Type 1 Diabetes

Orgenesis SPRL, a subsidiary of Orgenesis Inc., a leader in the emerging fields of cellular therapy and regenerative medicine, today announced that it has received the formal approval from the Walloon Region, Belgium (Service Public of Wallonia, DG06) for a €2.015 million support program for the research and development of a potential cure for Type 1 Diabetes.

26 Nov 2014

New Sophia DDM platform offers full BRCA1/2 analysis on a single NGS run

Sophia Genetics, the European leader in Clinical Genomics and Next Generation DNA Sequencing (NGS), has today launched a major upgrade to its Data Driven Medicine Platform (Sophia DDM), offering full BRCA1/2 analysis on a single NGS (Next Generation Sequencing) run, for the first time.

26 Nov 2014

Promethera Biosciences completes €25.33 million ($31.4 million) Series C fundraising

Promethera Biosciences, a Belgian biotechnology company developing Promethera HepaStem, a cell-based therapy for the treatment of in-born errors of metabolism and acquired liver diseases, today announces the completion of its Series C fundraising round. The company has raised €25.33 million ($31.4 million), including €20.33 million in capital.

26 Nov 2014

electroCore CEO highlights the importance of working with stakeholders when launching new technologies

JP Errico, founder and CEO of electroCore, speaking at The FT Global Pharmaceutical and Biotechnology Conference in London last week, emphasized the importance of working with each of the major stakeholders, i.e., patients and their advocates, key opinion-leading physicians, and decision-makers within the payor community at the earliest opportunity, particularly in regards to innovative and disruptive technology such as electroCore’s non-invasive vagus nerve stimulation (nVNS).

26 Nov 2014

UTSA's Bernard Arulanandam named fellow of AAAS

Bernard Arulanandam, UTSA Jane and Roland Blumberg Professor in Biology and Assistant Vice President for Research Support, has been named a fellow of the American Association for the Advancement of Science. Arulanandam was elected by his peers for the honor, recognizing his scientific and socially distinguished efforts to advance science and its applications.

26 Nov 2014

New hybrid vehicle to improve delivery of DNA vaccines is under development

Described recently in the Proceedings of the National Academy of Sciences, the technology is a biomedical advancement that could help unleash the potential of DNA vaccines, which despite two decades of research, have yet to make a significant impact in the treatment of major illnesses.

26 Nov 2014

Technology News and Research

Dresden scientists get access to the World's second-fastest computer for cancer research

New smartphone app may help improve prescribing of antibiotics within RCSI Hospitals Group

Calcivis announces completion of first clinical study of Caries Activity Imaging System

FDA issues Complete Response letter for Avanir’s AVP-825 NDA

External artificial pancreas improves glucose control, reduces hypoglycemia risk

Researchers show that iPS cells can be used to edit genetic mutations that cause DMD

Peek's smartphone eye examination tool could help tackle blindness

Innovative collar for MND patients to be showcased at NHS Innovation Challenge Prizes

Researchers discover why advanced melanoma patients respond to pembrolizumab drug

UT Arlington researcher receives grant to educate Hispanic patients about depression, treatment options

Genom Austria project to explore impact of genome sequencing on science and society

CARsgen announces completion of series A financing

Philips announces expanded availability of diagnostic X-ray solutions

Perc NGage® and Perc NCompass® nitinol stone extractors launched by Cook Medical

Orgenesis receives €2.015 million grant to develop potential cure for Type 1 Diabetes

New Sophia DDM platform offers full BRCA1/2 analysis on a single NGS run

Promethera Biosciences completes €25.33 million ($31.4 million) Series C fundraising

electroCore CEO highlights the importance of working with stakeholders when launching new technologies

UTSA's Bernard Arulanandam named fellow of AAAS

New hybrid vehicle to improve delivery of DNA vaccines is under development

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News